Chief Development Officer

🍊Our mission

Great science regularly stalls in the clinic, not because the science is wrong, but because the company behind it lacks the capital, infrastructure, or focus to take it all the way through. Today’s clinical-stage biopharma model is broken, and as a result promising treatments never reach patients.

Our mission is to fix this: we’re building the next generation of biopharma by in-licensing clinical-stage therapeutic assets and developing them through Lindus Health’s integrated, technology-first clinical trial infrastructure. We’re a new initiative, but we’re building on a proven foundation - the same infrastructure that has delivered 82% of Lindus Health’s sponsor trials on or ahead of timeline, across 40+ completed trials across the US and Europe.

We’re in-licensing 5-7 clinical-stage, typically Phase-2-ready assets, funded directly from Lindus Health’s balance sheet. We’re targeting deal close on our first assets through 2026, with first trials launching in H1 2027.

About the Role

As Chief Development Officer, you will own development strategy across the Lindus Therapeutics portfolio. We are building out a first tranche of 4 to 5 in-licensed assets, with trials starting in 2027.

You report to our CEO, lead the Lindus Tx team, manage our VP Corporate Development and asset leads, and sit on the company executive committee. You are the senior development voice on every asset: you determine whether and how each can be advanced quickly and capital-efficiently to a Phase 2 proof-of-concept readout that an acquirer will pay for. You set the development strategy, design the clinical studies, define the target product profile, and drive the regulatory path behind each program.

This is a hands-on builder's role. You won't run a large internal department: you'll assemble and direct a lean organization of fractional and consultant CMC, regulatory, pharmacology and clinical experts, with a development lead on each program reporting to you. Knowing how to find the right expert for each function matters as much here as the development science itself. You'll have real ownership: the call on whether an asset is developable and worth pursuing sits with you.

About You

• A senior clinical development leader. You have led clinical programs through Phase 1 and Phase 2 at pharma or biotech companies across more than one non-oncology therapeutic area. You've designed Phase 2 proof-of-concept studies, and you understand what it takes to generate a clean, interpretable signal in each. You've engaged with the FDA and ideally the EMA on IND strategy and early development interactions, and you know what the agencies will want to see at each stage.

• Experience with in-licensed and partnered assets. You have experience developing assets that originated from 3rd parties, can build a development plan based on gaps in the dataset and what a future partner or acquirer might want to see.

• You design around the exit. You understand what a potential acquirer needs to see in the clinical and CMC package at Phase 2 proof-of-concept, including the endpoints, the dose selection rationale and the biomarker strategy, and you build the program to get there without gold-plating it.

• Portfolio experience. You've led or overseen multiple programs simultaneously and are comfortable making hard prioritization calls between assets.

• Able to run lean in a biotech setting. You've delivered strong Phase 1 and Phase 2 data within tight constraints and you'd rather build development capability through a small core team and a network of specialists than a large internal department.

• A network to draw on. You can stand up regulatory, CMC, pharmacology and clinical capabilities as each asset needs them, bringing in the right people on the right terms.

• Comfortable with AI tools. You use them across research, planning and analysis, with a clear sense of where they help and where scientific judgment is needed.

What You'll Focus On

• Owning clinical development strategy across the LTx portfolio, determining how each asset reaches a value-generating Phase 2 proof-of-concept readout quickly and capital-efficiently.

• Take a voting position Lindus’ investment committee (alongside CEO and CMO), selecting which assets to in-license and develop

• Designing Phase 1 and Phase 2 studies, including FIH and dose-escalation strategy, endpoints, patient population, biomarker approach and go/no-go criteria, and building the regulatory and CMC plans behind them.

• Leading scientific and clinical diligence on shortlisted assets alongside the deal team and external experts, and making the developability call.

• Building and directing a virtual development organization: recruiting and managing fractional and consultant CMC, regulatory, pharmacology and clinical talent, and the development lead on each program.

• Designing each program backward from the exit, ensuring the Phase 2 clinical and CMC package is built for what a strategic or specialty pharma buyer will pay for.

• Partnering with the VP Corporate Development on asset evaluation, deal structuring and negotiation, providing the development view into diligence.

• Leading regulatory interactions with the FDA, EMA and other agencies, including pre-IND meetings, Type B interactions and scientific advice procedures.

• Representing LTx's development thesis with investors, partners and the board.

What We Offer

We believe in rewarding the people who are building the future of clinical research.

Financial & Growth

• Competitive salary plus meaningful equity; you'll own a piece of what we're building

• $2,000 annual Learning & Development budget for courses, certifications and conferences

Health & Wellbeing

• $800 monthly employer contribution toward insurance for US team members (via TriNet PEO)

• $40 monthly wellness allowance with flexibility on how to spend it, including company private health insurance or a Wellhub membership

• Access to gym and retail discounts through Happl

Culture & Connection

• Regular company events and team gatherings (both virtual and in-person)

• Charity partnerships and volunteering opportunities with Forward Trust

• Work with a team that's changing healthcare for the better

Our Hiring Process

We believe hiring should be transparent, respectful of your time, and give you a real feel for what Lindus Health is like. Here's what to expect:

1. Intro to Lindus Health with Cam (Senior Talent Partner) (45 mins)

2. Initial conversation with Michael Young (Co-CEO) (30 mins) — get to know each other, discuss the role, and answer any questions about Lindus and LTx

3. Second conversation with Meri Beckwith (Co-CEO) (30 mins) — get to know each other, discuss the role, and answer any questions about Lindus and LTx

4. Development and strategy interview with Meri plus a senior member of the Lindus Tx team (60 mins) — a prepared presentation: take a sample Phase 1-complete asset and outline how you'd advance it to a value-generating proof-of-concept readout, including the regulatory, CMC and exit path

5. Values interview with a co-founder and another member of the wider team (30 mins) — a chance to explore how our values align

6. Reference checks — quick conversations with previous colleagues

We will only contact you from lindushealth.com email addresses. Please check the spelling of emails which appear to come from Lindus carefully before responding. We will never ask for your financial information over email.

We are an equal opportunity employer committed to building a diverse and inclusive workforce. We evaluate all candidates based solely on their skills, experience, and qualifications relevant to the role. We do not discriminate on the basis of race, ethnicity, religion, gender, gender identity, sexual orientation, age, disability, veteran status, or any other legally protected status